Presentation on theme: "Reduction of Medicaid Expenditures from State Prescription Programs in Illinois and Wisconsin Donald S Shepard, PhD* Desiree Koh, * Cindy Thomas, PhD*"— Presentation transcript:
Reduction of Medicaid Expenditures from State Prescription Programs in Illinois and Wisconsin Donald S Shepard, PhD* Desiree Koh, * Cindy Thomas, PhD* Grant Ritter, PhD* Daniel Gilden,+ William Stason, MD,MS* Christine Bishop, PhD* *Brandeis University; +JEN Associates Supported by the Centers for Medicare & Medicaid Services under Contract No. CMS 500-00-0031/T.O. #2 to Brandeis University AcademyHealth Annual Research Meeting, June 8-10, 2008
22 Framework Prescription coverage Better use of drugs and medical services Maintain health Lower nursing home use Less Medicaid entry
33 Past research l Rector (2004), Safran (2005), Leung (2005) – About 30% of low income people skip some prescribed medications l Soumerai et al. (1991) –Limiting drugs to vulnerable population increased nursing home admissions l Gilman (2004) – Members of Prescription Assistance Programs (PAP) skip fewer doses than comparable controls l Shepard (2006) – SeniorCare halved risk of skimping l Leung (2005) – Risk is related to individual characteristics
44 Program background l In mid-2002, Illinois and Wisconsin initiated “SeniorCare” (SC) pharmacy assistance programs (PAPs) that provide low-income persons aged 65+ with publicly funded prescription drug assistance. l Maximum co-payments per prescription are generally $4 in IL and $15 in WI. l Enrollees with incomes up to 200% of the federal poverty limit (FPL) are funded under a Medicaid waiver designed to help seniors improve prescription drug use, maintain health and reduce financial vulnerability due to prescription costs.
55 Three strata studied l 68,292 Wisconsin members, who were all new enrollees (1,189 interviewed), l 121,000 Illinois members previously in Circuit Breaker, a limited PAP that excluded mental health and gastro-intestinal drugs and automatically rolled over into SC (termed ‘IL rollovers, 374 interviewed); l 47,782 Illinois members not previously in this PAP (termed ‘IL new,’ 664 interviewed).
77 Study Design for Medicaid Analysis l Ohio served as the comparison state. l Using Medicare claims and zip codes, matched Illinois and Wisconsin enrollees exactly on demographic and disease categories to similar Ohio Medicare beneficiaries. l Used propensity scores to match closely on disease severity and socio-economic characteristics based on census information and Social Security benefits.
88 Population Studied l Needed precise matching on income for examining Medicaid entry l Limited this analysis to buy-in Medicare beneficiaries in the three states Received subsidies for Medicare premiums and deductibles Qualified Medicare Beneficiaries, QMB Special Low Income Medicare Beneficiaries, SLMB l We matched 7,699 Illinois and 1,798 Wisconsin buy-in beneficiaries to comparable buy-in Ohio controls.
99 Research Objective: Evaluate First Year Impacts on l Nursing home entry l Medicaid entry l Medicaid expenditures
10 Approach l Descriptive analysis l Multivariate analysis
11 Nursing Home Entry among Wisconsin Buy-in Beneficiaries and Matched Ohio Controls
12 Medicaid Entry among Wisconsin Buy-in Beneficiaries and Matched Ohio Controls
13 Hazard Function for Nursing Home Entry, Wisconsin, part 1 VariableParameter Estimate Standard Error Statistical Signifi- cance Hazard Ratio Inpatient 0-3 Months of Index0.8580.2890.0032.357 Home Health 0-3 Months of Index0.0550.5440.9191.057 SNF 0-3 Months of Index0.1790.8240.8281.196 2001 JAI Morbidity Score0.0970.0650.1361.102 2001 Indicator for a Arthritis diagnosis0.0130.2430.9571.013 2001 Indicator for a Chronic heart disease diagnosis-0.2440.2510.3320.784 2001 Indicator for a Congestive heart failure diagnosis 0.3640.3090.2381.439 2001 Indicator for a COPD diagnosis-0.3930.2720.1490.675 2001 Indicator for a Cerebrovascular disease diagnosis 0.2050.3320.5361.228 2001 Indicator for a Diabetes diagnosis-0.2840.2610.2770.753
14 Hazard Function for Nursing Home Entry, Wisconsin, part 2 VariableParameter Estimate Standard Error Statistical Signifi- cance Hazard Ratio SSA Dept Count=1; SSA Pym (in 1,000s)0.0160.0370.6701.016 SSA Dept Count>1-3.1863.1310.3090.041 SSA Dep Count>1 * SSA Pymt (in 1,000s)0.2120.2180.3311.237 % Census Block: Income $0-$10,000-0.2671.2330.8290.766 % Census Block: Income $10,000-$20,000-0.2141.1570.8530.807 % Census Block: Income $20,000-$30,0000.7451.2340.5462.107 % Census Block: Income $30,000-$40,000-2.0371.4980.1740.130 % Census Block: Income >$40,0000.9521.1320.4002.591 % Census Block: HMO Participant-0.2950.2240.1880.745 State Rx Enrollee-0.6580.2170.002 0.518
19 Illinois summary l Due to preexisting PAP, SeniorCare did not reduce Medicaid entry, but did reduce nursing home entry and spending. l Cumulative rate of nursing home entry of Illinois SeniorCare buy-in beneficiaries (2.4%) was half the rate of the matched Ohio controls (4.4%). l Medicaid spending over the first year when averaged over all Illinois buy-in SeniorCare members (with standard errors of the mean) was $631 ($26) vs. $1,605 ($83) for matched buy-in Ohio controls l Per enrollee savings $974 ($87) or 61%. l Savings in Illinois did not quite equal the state’s share of first-year program costs per enrollee year ($1,394).
20 Wisconsin summary l SeniorCare buy-in enrollees had half the rate Medicaid entry in the first year (11%) than matched Ohio controls (22%) l Wisconsin SC had half the rate of nursing home entry (2.2%) compared to Ohio controls (4.5%) l Had $1,190 ($163) or 81% lower Medicaid spending per buy-in enrollee. l Wisconsin savings on buy-ins were greater than the state’s share of first-year program costs per enrollee year ($1,032).
21 Extrapolation possible? l Question: Do the data allow examining impacts on nursing home and Medicaid for all SeniorCare enrollees? l Answer: No l Why not? Ascertainment of income
27 Conclusions l 50% reductions in skimping applied to all SeniorCare enrollees l Comparable declines in nursing home entry among buy-ins. l First year savings in buy-in population not quite enough to pay for the program costs in Illinois l These savings were more than sufficient in Wisconsin. l Prescription drug coverage for vulnerable populations pays off with less nursing home entry and lower costs.
28 Limitations l Differences in nursing home and Medicaid policies among states could confound interpretation
29 Strength: Consistent improvements in l Self reported behavior (skimping) l Costly services (nursing home entry) l Medicaid expenditures
30 Research implications l Observations and natural experiments very powerful. l Must understand and control for selection effects. l Stay within the data.
31 Policy implications l Enrollment of needy elders in both states benefited from outreach, straightforward design, and federal subsidies that extended to 200% of the FPL. l These findings show the value of completing “coverage” with access to prescription drugs.
Your consent to our cookies if you continue to use this website.